Infosys files amended US antitrust claims against Cognizant in trade secret battle
MLex Summary: Infosys filed amended US claims accusing Cognizant of leveraging monopoly power to obstruct competition against Helix, its healthcare platform. In a trade secret case filed by Cognizant, Infosys brought...To view the full article, register now.
Already a subscriber? Click here to view full article